OCT 30, 2014 12:00 AM PDT

Cancer Study In Mice Brings Hope For Human Patients

A study conducted at the University of Chicago's Center for Personalized Therapeutics has shown remarkable results in eliminating human tumors that have been transplanted into mice. The new research, reported in the journal Science Translational Medicine, highlighted two drugs that were extremely effective and produced little or no side effects.

The drugs, OTS964 and its precursor OTS514, were given to mice that had been implanted with human cancer tumors. The drugs were given in two forms, intravenously and orally. Initially, the drugs showed toxicity to red and white blood cells, however once it was encased in liposomes, this toxicity was eliminated in the intravenous form and easily managed in the oral form.

The molecular target of this drug has been known for over a decade. TOPK (T-lymphocyte-activated killer cell-originated protein kinase) has always been associated with tumor growth. The protein is present in many kinds of human cancers, but the study looked at an especially aggressive lung tumor, LU-99. Researchers grew the tumors on the mice to 150 cubic millimeters and then injected the mice with OTS964, twice a week for three weeks. In five out of six of the mice, the tumors were completely eliminated. Even after the drug was stopped, the tumors continued to shrink.

The drug worked by preventing the tumor cells from dividing. TOPK is the agent that allows cancer cells to rapidly divide and spread disease. Without this protein, the cancer cells failed to divide and grow and essentially withered and died.

University of Chicago Professor of Medicine, Yusuke Nakamura, was excited by the results. "It is rare to see complete regression of tumors in a mouse model," he said. "Many drugs can repress the growth but it is uncommon to see them eradicated. This has rarely been reported."

Phase 1 clinical trials of the drug could begin as early as the fall of 2015
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
OCT 21, 2019
Cancer
OCT 21, 2019
Do fat cells make melanoma turn aggressive?
New research published in the journal Science Signaling suggests surprising insight on melanoma, which although only accounts for 1% of skin cancer diagnos...
OCT 21, 2019
Microbiology
OCT 21, 2019
A Canine Cancer That Began to Spread From One Dog About 6,000 Years Ago
Dogs can get different kinds of cancers, including one that is transmitted by live cancer cells, which spread through sexual contact....
OCT 21, 2019
Cancer
OCT 21, 2019
Treating dogs with human breast cancer drugs
Did you know that dogs get lung cancer? New research published recently in the journal Clinical Cancer Research shows how dogs with cancer are benefiting f...
OCT 21, 2019
Cardiology
OCT 21, 2019
Exercise Produces Greater Benefits In Those With Cardiovascular Disease
The fact that exercise benefits the heart and can help a person live a longer healthier life is well established. Exercising regularly can improve quality...
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
Genetic Cause for Tumor Progression
Researchers from the University of Delaware (UDEL), Harvard Medical School (HMS) and University of California, Los Angeles (UCLA), have discovered a ribonu...
OCT 21, 2019
Cancer
OCT 21, 2019
An alternative for immunotherapy-resistant cancer patients
A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targe...
Loading Comments...